Crinetics Pharmaceuticals Announces Executive and Board Changes
Ticker: CRNX · Form: 8-K · Filed: Sep 17, 2024 · CIK: 1658247
| Field | Detail |
|---|---|
| Company | Crinetics Pharmaceuticals, Inc. (CRNX) |
| Form Type | 8-K |
| Filed Date | Sep 17, 2024 |
| Risk Level | medium |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: executive-changes, board-changes, personnel
Related Tickers: CRNX
TL;DR
CRNX board and exec shakeup: Wood in as CMO & Director, Wood out as Director.
AI Summary
Crinetics Pharmaceuticals, Inc. announced on September 13, 2024, changes in its executive team and board of directors. Specifically, Dr. David J. E. Wood was appointed as Chief Medical Officer, and Dr. David J. E. Wood was appointed to the Board of Directors. The company also announced the departure of Dr. David J. E. Wood from the Board of Directors.
Why It Matters
Changes in key leadership roles and board composition can signal shifts in company strategy, operational focus, or future direction.
Risk Assessment
Risk Level: medium — Executive and board changes can introduce uncertainty regarding future strategy and execution.
Key Players & Entities
- Crinetics Pharmaceuticals, Inc. (company) — Registrant
- Dr. David J. E. Wood (person) — Appointed Chief Medical Officer and Board Director
- Dr. David J. E. Wood (person) — Departed Board of Directors
- September 13, 2024 (date) — Date of earliest event reported
FAQ
Who has been appointed as the new Chief Medical Officer?
Dr. David J. E. Wood has been appointed as the new Chief Medical Officer.
When were these changes reported?
These changes were reported as of September 13, 2024.
Has Dr. David J. E. Wood joined the Board of Directors?
Yes, Dr. David J. E. Wood has been appointed to the Board of Directors.
Who has departed from the Board of Directors?
Dr. David J. E. Wood has departed from the Board of Directors.
What is the principal executive office address of Crinetics Pharmaceuticals, Inc.?
The principal executive office address is 6055 Lusk Boulevard, San Diego, California 92121.
Filing Stats: 494 words · 2 min read · ~2 pages · Grade level 11.5 · Accepted 2024-09-17 16:05:40
Key Financial Figures
- $0.001 — ch registered Common Stock, par value $0.001 per share CRNX Nasdaq Global Select
Filing Documents
- crnx-20240913.htm (8-K) — 37KB
- 0000950170-24-107259.txt ( ) — 144KB
- crnx-20240913.xsd (EX-101.SCH) — 23KB
- crnx-20240913_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. Crinetics Pharmaceuticals, Inc. Date: September 17, 2024 By: /s/ R. Scott Struthers, Ph.D. R. Scott Struthers, Ph.D. President and Chief Executive Officer (Principal Executive Officer)